Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Accelerated Approval

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Mar 12, 2021 12:40pm

301 Views

Post# 32786048

RE:RE:RE:Accelerated Approval

Good to see that the FDA is challenging Big Pharma on these drugs. Even if BP has ways to put pressure on the FDA, we see that in the end data is King. May TLD-1433 be the supreme King in bladder cancer with unparalleled data, and GBM and NSCLC to follow.